Devices containing artificial membranes for the treatment of kidney disease lack the ability to replace or augment metabolic and endocrine functions, which are non-selective and biologically reactive.
Care providers must consider some key factors they need to balance for effective implementation of patient-centric modalities
Medical devices and their components are currently being scaled down to molecular levels and successfully applied in diagnostics and clinical therapies.
Combination products have the potential to respond to the increase in patient needs in a way that may be more affordable, easier to use, less expensive, or more effective than current solutions.
Combination products will enable healthcare providers to treat diseases with localised drug delivery and fewer side effects.
With the application of the generic pharmaceutical model to off-patent devices, the availability of generic alternatives to branded medical devices presents an opportunity for a drastic reduction in healthcare costs.
The constellation of technologies that make up a modern CyberKnife system enable radiosurgery to be delivered with sub-millimeter accuracy to static lesions and better than 2 mm accuracy to targets that move with respiration.
Implanted medical devices present different security issues than traditional information systems, and require different security risk analysis and mitigation techniques
The amount of aero-allergence in areas where powdered gloves are worn can increase 5-10 fold when compared to those where only powder free gloves are used.
Developing a product pipeline is being considered seriously and will be an essential factor for the growth of the Indian pharma market.
Biosimilars will eventually bring down the cost of biological medicines and in doing so will expand the market.
Non-invasive methods to monitor ventilation are valid surrogates for arterial blood gas analysis.